ETPrime

Lupin Share Price

  • 1,947.203.30 (0.17%)
  • Volume: 3,29,889
  • Closed
  • Last Updated On: 08 Sep, 2025, 03:41 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Lupin Share Price
  • 1,947.203.30 (0.17%)
  • Volume: 3,29,889
Advertisment
Stock Recommendations

  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
35 Analysts

0

2

13

12

8

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Lupin share price insights

View All

  • Company delivered ROE of 19.07% in year ending Mar 31, 2025 outperforming its 5 year avg. of 7.6%. (Source: Consolidated Financials)

  • Company's annual revenue growth of 13.77% outperformed its 3 year CAGR of 11.32%. (Source: Consolidated Financials)

  • Daily MACD crossover appeared yesterday. Average price gain of 3.71% within 10 days of this signal in last 10 years.

  • Company has spent 1.3% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Lupin Ltd. share price moved up by 0.17% from its previous close of Rs 1,943.90. Lupin Ltd. stock last traded price is 1,947.20

    Share PriceValue
    Today/Current/Last1,947.20
    Previous Day1,943.901,944.65

InsightsLupin

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		24.04
    EPS - TTM
    (₹)    		81.00
    MCap
    (₹ Cr.)    		88,931.76
    Sectoral MCap Rank
    		8
    PB Ratio
    (x)    		5.13
    Div Yield
    (%)    		0.62
    Face Value
    (₹)    		2.00
    Beta

    Beta

    1 Month0.04
    3 Months0.57
    6 Months0.59
    1 Year0.76
    3 Years0.87

    		0.04
    VWAP
    (₹)    		1,950.27
    52W H/L
    (₹)
    2,402.90 / 1,795.20

    Lupin Share Price Returns

    1 Day0.17%
    1 Week2.59%
    1 Month1.52%
    3 Months-2.62%
    1 Year-13.71%
    3 Years192.04%
    5 Years111.76%

    ET Stock ScreenersTop Score Companies

    Check whether Lupin belongs to analysts' top-rated companies list?

    View Stock Screeners

    Lupin News & Analysis

    View all Lupin Share News & Announcements

    Lupin Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 35 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy
    • Target₹2500
    • OrganizationAxis Securities
    • OVERWEIGHT
    • Target₹2600
    • OrganizationAxis Securities
    • OVERWEIGHT

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy8876
    Buy12121212
    Hold13131311
    Sell2224
    Strong Sell----
    # Analysts35353433
    View all Stock Recommendations

    Lupin Financials

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 13.77% outperformed its 3 year CAGR of 11.32%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 1.3% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income6,347.385,724.085,821.425,715.025,668.11
      Total Income Growth (%)10.89-1.671.860.8313.59
      Total Expenses4,840.084,739.144,683.264,589.294,607.07
      Total Expenses Growth (%)2.131.192.05-0.394.21
      EBIT1,507.30984.941,138.161,125.731,061.04
      EBIT Growth (%)53.03-13.461.106.1086.47
      Profit after Tax (PAT)1,219.03772.52855.16852.63801.31
      PAT Growth (%)57.80-9.660.306.40122.94
      EBIT Margin (%)23.7517.2119.5519.7018.72
      Net Profit Margin (%)19.2113.5014.6914.9214.14
      Basic EPS (₹)26.7016.9318.7518.7017.58
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income5,762.734,534.464,263.304,138.824,205.85
      Total Income Growth (%)27.096.363.01-1.5922.72
      Total Expenses3,155.682,947.523,026.693,137.223,109.38
      Total Expenses Growth (%)7.06-2.62-3.520.904.15
      EBIT2,607.051,586.941,236.611,001.601,096.47
      EBIT Growth (%)64.2828.3323.46-8.65148.27
      Profit after Tax (PAT)2,128.071,291.35984.67807.76889.18
      PAT Growth (%)64.7931.1521.90-9.16131.51
      EBIT Margin (%)45.2435.0029.0124.2026.07
      Net Profit Margin (%)36.9328.4823.1019.5221.14
      Basic EPS (₹)46.6028.3021.5817.7119.51
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue22,903.7220,130.9916,715.0216,547.1715,299.25
      Total Revenue Growth (%)13.7720.441.018.16-3.53
      Total Expenses18,888.7217,708.7215,998.5317,919.7413,624.13
      Total Expenses Growth (%)6.6610.69-10.7231.53-5.08
      Profit after Tax (PAT)3,281.621,914.48430.08-1,528.041,216.53
      PAT Growth (%)71.41345.15--225.61-
      Operating Profit Margin (%)18.9713.665.95-7.4911.97
      Net Profit Margin (%)14.459.562.58-9.318.02
      Basic EPS (₹)71.9542.059.46-33.6526.84
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue17,141.5514,773.2311,350.0911,922.0911,185.02
      Total Revenue Growth (%)16.0330.16-4.806.59-2.75
      Total Expenses12,227.2111,988.5410,822.9512,083.629,555.32
      Total Expenses Growth (%)1.9910.77-10.4326.46-1.38
      Profit after Tax (PAT)3,972.962,326.09425.21-188.701,258.62
      PAT Growth (%)70.80447.04--114.9972.99
      Operating Profit Margin (%)29.4619.375.55-0.7415.10
      Net Profit Margin (%)23.4115.853.77-1.6011.38
      Basic EPS (₹)87.1051.109.35-4.1627.77

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets29,204.8823,997.1822,955.9321,821.2223,610.44
      Total Assets Growth (%)21.704.545.20-7.58-5.50
      Total Liabilities11,910.539,623.7310,413.119,599.249,752.33
      Total Liabilities Growth (%)23.76-7.588.48-1.57-21.37
      Total Equity17,294.3514,373.4512,542.8212,221.9813,858.11
      Total Equity Growth (%)20.3214.602.63-11.8110.15
      Current Ratio (x)1.871.581.341.511.66
      Total Debt to Equity (x)0.300.190.340.320.22
      Contingent Liabilities644.691,148.59942.951,050.68611.28
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets28,431.9924,922.8622,683.6722,313.3721,858.56
      Total Assets Growth (%)14.089.871.662.085.70
      Total Liabilities4,153.754,319.774,271.814,163.183,292.99
      Total Liabilities Growth (%)-3.841.122.6126.432.67
      Total Equity24,278.2420,603.0918,411.8618,150.1918,565.57
      Total Equity Growth (%)17.8411.901.44-2.246.25
      Current Ratio (x)3.602.512.092.383.72
      Total Debt to Equity (x)0.000.000.030.040.02
      Contingent Liabilities3,288.403,837.264,214.684,058.715,051.40

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 4171.89 cr for investing activities which is an YoY increase of 143.66%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities2,999.943,648.361,897.24367.311,821.76
      Net Cash used in Investing Activities-4,171.89-1,712.20-1,286.771,292.23-1,239.58
      Net Cash flow from Financing Activities1,731.88-2,184.21-337.25-1,572.32-1,885.27
      Net Cash Flow559.93-248.05273.2287.22-1,303.09
      Closing Cash & Cash Equivalent1,543.69983.761,264.591,013.44926.22
      Closing Cash & Cash Equivalent Growth (%)56.92-22.2124.789.42-58.45
      Total Debt/ CFO (x)1.690.732.2410.471.68
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities2,444.652,504.131,793.99151.031,570.08
      Net Cash used in Investing Activities-1,766.32-1,599.02-1,269.17-371.79-2,507.52
      Net Cash flow from Financing Activities-460.23-867.07-498.26102.45-53.17
      Net Cash Flow218.1038.0426.56-118.31-990.61
      Closing Cash & Cash Equivalent341.80123.7085.6659.10177.41
      Closing Cash & Cash Equivalent Growth (%)176.3144.4144.94-66.69-84.81
      Total Debt/ CFO (x)0.000.010.345.230.19

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 19.07% in year ending Mar 31, 2025 outperforming its 5 year avg. of 7.6%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)19.0713.393.45-12.578.81
      Return on Capital Employed (%)21.2917.647.23-9.0711.96
      Return on Assets (%)11.237.971.87-7.005.15
      Interest Coverage Ratio (x)18.5812.616.823.0012.91
      Asset Turnover Ratio (x)0.850.850.510.5164.22
      Price to Earnings (x)28.2538.6168.97-22.2238.17
      Price to Book (x)5.385.162.362.793.36
      EV/EBITDA (x)17.2619.1517.3785.6217.65
      EBITDA Margin (%)24.1219.6411.242.6117.82
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)16.3611.292.30-1.036.77
      Return on Capital Employed (%)19.8913.383.28-0.468.66
      Return on Assets (%)13.979.331.87-0.845.75
      Interest Coverage Ratio (x)66.8263.2811.935.8041.12
      Asset Turnover Ratio (x)0.640.620.500.5350.57
      Price to Earnings (x)23.3131.7569.44-181.8236.90
      Price to Book (x)3.813.581.601.872.49
      EV/EBITDA (x)16.3120.6425.5581.2821.32
      EBITDA Margin (%)33.2724.3110.423.6119.65

    Financial InsightsLupin

    • Income (P&L)
    • Cash Flow
    • Ratios

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 13.77% outperformed its 3 year CAGR of 11.32%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 1.3% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 4171.89 cr for investing activities which is an YoY increase of 143.66%. (Source: Consolidated Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 19.07% in year ending Mar 31, 2025 outperforming its 5 year avg. of 7.6%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Lupin Share Price Forecast

    • Get multiple analysts’ prediction on Lupin

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Lupin

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Lupin

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Lupin Technicals

    • Bullish / Bearish signals for Lupin basis selected technical indicators and moving average crossovers.

      MACD Crossover

      Bullish signal on daily chart

      Appeared on:

    Lupin Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Lupin24.045.1419.0721.2911.2311.3218.9714.5571.951.870.301.69
          Cipla23.093.9816.9021.5714.108.7324.9819.2065.294.250.000.02
          Torrent Pharma61.0816.1125.1728.7112.759.7525.6116.5956.471.190.401.17
          Mankind Pharma56.247.3113.8913.277.1716.7224.0316.3749.281.230.593.51
          Dr. Reddys18.373.0816.8521.8111.4415.1124.3217.4767.891.920.120.90
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Cadila Healthcare
          • Alkem Labs
          • Aurobindo Pharma
          • Glenmark Pharma
          • Biocon

          Choose from Stocks

            See All Parameters

          Peers InsightsLupin

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Lupin Shareholding Pattern

            • Loading...
              Showing Lupin Shareholding as on Jun 2025
              CategoryJun 2025Mar 2025Dec 2024Sep 2024
              Promoters46.9046.9246.9546.96
              Pledge0.000.000.000.00
              FII21.2521.4622.0421.50
              DII25.5525.4124.7325.06
              Mutual Funds19.3517.5516.9216.89
              Others6.296.216.276.47
            • Showing Shareholding as on Jun 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters21,42,07,51446.90 %-0.02
              Pledge00.00 %0.00
              FII9,70,57,76221.25 %-0.21
              DII11,67,18,00725.55 %0.14
              MF8,83,82,76919.35 %1.80
              Others2,87,32,8406.29 %0.08

            Lupin MF Ownership

            MF Ownership as on 31 July 2025

            View all Mutual Fund Schemes
            Top Searches:
            Lupin News Lupin Quarterly Results Lupin Dividend Lupin Q1 ResultsLupin Q2 ResultsLupin Q3 ResultsLupin Q4 Results

            Lupin F&O Quote

              • Expiry

              Price

              1,953.504.20 (0.22%)

              Open Interest

              1,06,53,900-116,875 (-1.09%)

              OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
              1,923.101,966.001,923.001,949.301,64713,672.19

              Open Interest as of 08 Sep 2025

              • Type
              • Expiry
              • Strike Price

              Price

              39.20-0.35 (-0.88%)

              Open Interest

              1,70,0008,075 (4.99%)

              OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
              34.0045.1530.4539.551,0839,208.81

              Open Interest as of 08 Sep 2025

            Lupin Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Sep 29, 2025Aug 26, 2025POM-
              Aug 11, 2025Jul 14, 2025AGM-
              Aug 05, 2025Jul 22, 2025Board MeetingQuarterly Results & Others
              May 14, 2025Apr 29, 2025Board MeetingAudited Results & Final Dividend
              Mar 24, 2025Feb 18, 2025POM-
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final600%12.0Jul 25, 2025May 14, 2025
              Final400%8.0Jul 16, 2024May 06, 2024
              Final200%4.0Jul 14, 2023May 10, 2023
              Final200%4.0Jul 14, 2022May 18, 2022
              Final325%6.5Jul 27, 2021May 14, 2021
            • All TypesEx-DateRecord DateAnnounced onDetails
              SplitsAug 27, 2010Aug 30, 2010May 05, 2010Split: Old FV10.0| New FV:2.0
              BonusAug 11, 2006Aug 14, 2006May 17, 2006Bonus Ratio: 1 share(s) for every 1 shares held

            About Lupin

            Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 88,931.76 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Services, Other Operating Revenue, Scrap and Service Income for the year ending 31-Mar-2025. Show More

            • Executives

            • Auditors

            • MD

              Manju D Gupta

              Chairperson
              ND

              Nilesh D Gupta

              Managing Director
              VG

              Vinita Gupta

              Chief Executive Officer
              VG

              Vinita Gupta

              Director & CEO
              Show More
            • B S R & Co. LLP

            Industry

            Pharma - Indian

            Key Indices Listed on

            Nifty Midcap 50, Nifty Midcap 100, Nifty 200, + 43 more

            Address

            Kalpataru Inspire,3rd Floor,Off. Western Express Highway,Mumbai, Maharashtra - 400055

            Contact

            info@lupin.com

            http://www.lupin.com

            More Details

            FAQs about Lupin share

            • 1. What is Lupin share price and what are the returns for Lupin share?
              Lupin share price is Rs 1,947.20 as on 08 Sep, 2025, 03:47 PM IST. Lupin share price is up by 0.17% based on previous share price of Rs 1,939.2. Lupin share price trend:
              • Last 3 Months: Lupin share price moved down by 2.62%
              • Last 12 Months: Lupin share price moved down 13.71%
              • Last 3 Years: Lupin Share price moved up by 192.04%
            • 2. What is Lupin's 52 week high / low?
              Lupin share price saw a 52 week high of Rs 2,402.90 and 52 week low of Rs 1,795.20.
            • 3. What is the PE & PB ratio of Lupin?
              The PE ratio of Lupin stands at 24.0, while the PB ratio is 5.13.
            • 4. What's the market capitalization of Lupin?
              Within the Pharmaceuticals sector, Lupin stock has a market cap rank of 8. Lupin has a market cap of Rs 88,931.76 Cr.
            • 5. What are the returns for Lupin share?
              Return Performance of Lupin Shares:
              • 1 Week: Lupin share price moved up by 2.59%
              • 3 Month: Lupin share price moved down by 2.62%
              • 6 Month: Lupin share price moved down by 4.08%

            Trending in Markets

            Top Gainers As on 03:59 PM | 08 Sep 2025

            Suven Pharma 1,012.95
            90.06 (9.76%)
            Guj Mineral Dev.539.15
            30.15 (5.93%)
            Bharat Forge1,202.80
            66.10 (5.82%)
            Ashok Leyland137.29
            6.52 (4.99%)
            JP Power20.02
            0.95 (4.99%)

            Top Losers As on 03:57 PM | 08 Sep 2025

            Amber Enterprises7,473.00
            -320.50 (-4.12%)
            EID Parry1,067.30
            -45.50 (-4.09%)
            Trent5,315.50
            -213.00 (-3.86%)
            Godfrey Philips10,657.00
            -416.00 (-3.76%)
            Coromandel Int.2,185.20
            -72.71 (-3.22%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Lupin Share Price
            The Economic Times
            BrowseCompanies: